Susan McArdle

Title: Susan McArdle: Innovator in HIV Research

Introduction

Susan McArdle is a notable inventor based in King, WA (US). She has made significant contributions to the field of immunology, particularly in the study of Human Immunodeficiency Virus (HIV). Her innovative work has led to advancements in the detection and understanding of this critical virus.

Latest Patents

Susan McArdle holds a patent for the "Expression of immunologically reactive HIV envelope proteins." This patent describes a method for expressing proteins that are immunologically reactive with antibodies to lymphadenopathy-associated virus (LAV), now known as HIV. The proteins are produced by bacterial host cells transformed with a recombinant plasmid that includes appropriate procaryotic transcriptional and translational signals for expression. This method allows for the production of proteins that can be used to screen for the presence of antibodies to LAV in biological fluids, determine the presence of LAV antigen, or produce antibodies to LAV through immunization of animals with the protein. She has 1 patent to her name.

Career Highlights

Susan McArdle is currently associated with Bristol-Myers Squibb Company, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of HIV and its interactions with the immune system.

Collaborations

Some of her notable coworkers include Suan M Watanabe and Wesley Loren Cosand. Their collaborative efforts contribute to the ongoing research and development in the field of immunology.

Conclusion

Susan McArdle's innovative contributions to HIV research highlight her role as a significant inventor in the field. Her work not only advances scientific understanding but also has practical applications in the detection and treatment of HIV.